Patent intelligence · EP
EP 1393713
Flüssiges Konzentrat zur Konservierung kosmetischer und pharmazeutischer Produkte
Flüssiges Konzentrat zur Konservierung kosmetischer und pharmazeutischer Produkte
Patent details — EP 1393713
- Jurisdiction
- EP
- Status
- expired
- Grant date
- Mar 3, 2004
- Expiration
- Feb 27, 2024
- Applicant
- AIR LIQUIDE SANTE FRANCE [FR]
- CPC classes
- A61K 8/ 00 A I, A61K 8/ 33 A I, A61K 8/ 34 A I, A61K 8/ 35 A I
Quick answer
EP 1393713 (Flüssiges Konzentrat zur Konservierung kosmetischer und pharmazeutischer Produkte) is held by AIR LIQUIDE SANTE FRANCE [FR]. Status: expired. Granted Mar 3, 2004. Expires Feb 27, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AIR LIQUIDE SANTE FRANCE [FR]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 8/ 00 A I, A61K 8/ 33 A I, A61K 8/ 34 A I, A61K 8/ 35 A I, A61K 8/ 36 A I, A61K 8/ 37 A I
More from AIR LIQUIDE SANTE FRANCE [FR]
Related pharmaceutical patents in our USPTO index.
-
US 2016030472
XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY
granted -
CA 2938043
MELANGE GAZEUX NO/HE A ACTION BACTERICIDE
granted -
CA 2866861
TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE
granted -
CA 2853911
PROCEDE DE FABRICATION DE MELANGES GAZEUX NO/N2 DESTINES AU DOMAINE MEDICAL
granted -
CA 2874019
MELANGE GAZEUX NO/AZOTE A TENEUR ELEVEE EN NO POUR TRAITER LES DETRESSES RESPIRATOIRES HYPOXEMIANTES SEVERES
granted -
FR 2964876
COMPOSITION ANESTHESIQUE GAZEUSE A BASE DE XENON UTILISABLE PENDANT UNE ENDARTERIECTOMIE AVEC CLAMPAGE DE L'ARTERE CAROTIDE
granted -
US 2011003857
STABILIZED, ANTIMICROBIALLY EFFECTIVE COMPOSITION WITH A CONTENT OF BISPYRIDINIUM ALKANE
granted -
US 2010331426
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
granted
Frequently asked questions
What is US patent 1393713?
EP 1393713 (Flüssiges Konzentrat zur Konservierung kosmetischer und pharmazeutischer Produkte) is held by AIR LIQUIDE SANTE FRANCE [FR]. Status: expired. Granted Mar 3, 2004. Expires Feb 27, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 1393713?
AIR LIQUIDE SANTE FRANCE [FR] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does EP 1393713 expire?
Our index shows an expiration date of Feb 27, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.